Medicine and Dentistry
Maturity Onset Diabetes of the Young
100%
Dapagliflozin
90%
Patient
90%
Glucose
85%
Therapeutic Procedure
66%
Cells
63%
Adipocyte
61%
Plasma
51%
Insulin
47%
Gluconeogenesis
47%
Insulin Resistance
43%
Adipose Tissue
42%
Placebo
42%
Inpatient
42%
Obesity
38%
Insulin Sensitivity
38%
Combination Therapy
36%
Adiponectin
34%
Leptin
32%
Insulin Release
32%
Glucagon-Like Peptide-1 Agonist
31%
Glucosuria
27%
Patient with Type 2 Diabetes
25%
Exenatide
24%
Pioglitazone
21%
Heart
21%
Chronic Kidney Disease
21%
Cell Function
21%
Cardiovascular System
21%
Hyperglycemia
21%
Glucagon
20%
Glycemic Control
19%
Paget's Disease
18%
Diabetes
18%
Lipid Diet
18%
Cardiovascular Disease
17%
Glucose Tolerance
17%
Osteoclast
16%
Oral Glucose Tolerance Test
15%
White Adipose Tissue
15%
Regulatory Mechanism
15%
Kidney
13%
Hypercalcaemia
13%
Serositis
13%
Antidiabetic Agent
13%
Body Weight
13%
Gene
12%
Cotransporter
12%
Weight Loss
12%
Bone
12%
Development
12%
Mineralocorticoid Antagonist
12%
Fat
12%
Hypoglycemia
11%
Health Outcomes
11%
Diabetes Mellitus
11%
Male
11%
Metabolism
11%
Type 2 Diabetes
11%
Chemotherapeutic Agent
11%
Drug
11%
Empagliflozin
10%
Creatine Phosphate
10%
Pheochromocytoma
10%
Iron
10%
Cannabinoid 1 Receptor
10%
Vascular Disease
10%
Osteoclast Differentiation Factor
10%
Hepatocyte Nuclear Factor 4
10%
Peroxisome Proliferator Activated Receptor
10%
Gonadorelin Agonist
10%
Calcium Excretion
10%
Primary Hyperparathyroidism
10%
Finerenone
10%
Patient with Type 1 Diabetes
10%
Semaglutide
10%
Human Study
10%
Physical Activity
10%
Musculoskeletal Health
10%
Meta-Analysis
10%
Placebo
10%
Absorptiometry
10%
Ketone
10%
Case Report
10%
Evaluation Study
9%
Adenosine Triphosphate
9%
Observation
9%
Association
9%
C-Peptide
9%
Adverse Event
9%
Glucose Uptake
9%
Diseases
9%
Chronic Myelogenous Leukemia
9%
Acipimox
9%
Hemoglobin A1c
9%
Connexin 43
8%
Hypophysis Apoplexy
8%
Deterioration
8%
Urinary System
8%
Drug Therapy
7%
Biochemistry, Genetics and Molecular Biology
Mouse
60%
Adipocyte
52%
Glucose
41%
Insulin Release
22%
Fat
19%
Knockout Mouse
17%
Dapagliflozin
17%
Gluconeogenesis
16%
Insulin Resistance
14%
Adiponectin
14%
Free Fatty Acids
13%
Peptide
12%
Hyaluronan
10%
Galactose
10%
Pyruvate Kinase
10%
Iron
10%
Dimethyl Sulfoxide
10%
Lipid Droplet
10%
Bile Acid Synthesis
10%
Bile Acid
10%
Syntaxin
10%
Hepatocyte Nuclear Factor 4
10%
Calcium Excretion
10%
Calcium Urine Level
10%
Ossification
10%
Human Study
10%
Physical Activity
10%
Insulin
10%
Nested Gene
10%
Metabolic Pathway
9%
Glucose Blood Level
9%
Excretion
8%
Glucose Metabolism
8%
Electric Potential
8%
Lysozyme
7%
Lipolysis
7%
Cotransporter
7%
Osteolysis
6%
Mouse Model
6%
Transmembrane Protein
6%
Glucose Homeostasis
6%
Phenotype
6%
Lipid
6%
Pressure
6%
Insulin Sensitivity
5%
Drive
5%
Glycerol
5%
Receptor Agonists
5%
Parathyroid Hormone
5%
Scanning Electron Microscopy
5%
Energy Transfer
5%
Heart Muscle Metabolism
5%
Energy
5%
Calcium
5%
Regulatory Mechanism
5%
Reduction (Chemistry)
5%
Lipid Metabolism
5%
Pharmacology, Toxicology and Pharmaceutical Science
Non Insulin Dependent Diabetes Mellitus
35%
Leptin
32%
Mouse
23%
Semaglutide
21%
Pioglitazone
21%
Adiponectin
20%
Dapagliflozin
19%
Obesity
17%
Insulin Resistance
16%
Glucose
13%
Insulin
11%
Vascular Disease
10%
Liraglutide
10%
Bile Acid
10%
Dimethyl Sulfoxide
10%
Liver Injury
10%
Prasterone
10%
Semaglutide
10%
Linagliptin
10%
Empagliflozin
10%
Hepatocyte Nuclear Factor 4
10%
Nonalcoholic Fatty Liver
10%
Peroxisome Proliferator Activated Receptor
10%
Muscone
10%
Primary Hyperparathyroidism
10%
Hyperleptinemia
10%
Placebo
10%
Glucagon Like Peptide 1 Receptor Agonist
10%
Glitazone Derivative
8%
Drug
8%
Antidiabetic Agent
7%
Adverse Event
7%
Diseases
7%
Placebo
7%
Diethylstilbestrol
6%
Osteoporosis
6%
Leptin Deficiency
6%
Estrogen
5%
Luciferase
5%
Hyperglycemia
5%
Saxagliptin
5%
Clinical Trial
5%
Traditional Chinese Medicine
5%
Syndrome
5%
Calcium
5%
Diet Induced Obesity
5%